Jourdan Waddell to Diabetes Mellitus, Type 2
                            
                            
                                This is a "connection" page, showing publications Jourdan Waddell has written about Diabetes Mellitus, Type 2.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.144
         
        
        
     
 
    
        
        - 
            Discontinuation and non-publication rates of U.S. clinical trials for the pharmacologic treatment of type 2 diabetes mellitus: A cross-sectional analysis. Diabetes Metab. 2022 Mar; 48(2):101317.
            
            
                Score: 0.144